Retinal Protection Sciences (RPS) is focused on maximizing quality of life by preserving vision and preventing vision loss. RPS has developed a novel platform device - SAPRA™ - built around an optimized treatment regimen (Vision Protection Therapy™) that normalizes retinal function at the cellular level and prevents both disease onset and progression. Once validated in a pivotal clinical trial, RPS will be uniquely positioned to establish a preventative standard of care for ophthalmology.

SAPRA™ has not yet been evaluated and approved by the U.S. FDA or regulators for other geographies for commercial sales.

Retinal Protection Sciences

Org chart

Teams

Offices

Retinal Protection Sciences

Org chart

Teams

Offices

Related companies